Logo
x

Search

Subscribe Now

immunotherapies

Gilead Signs an Option and License Agreement with Gritstone for HIV Vaccine

Gilead Signs an Option and License Agreement with Gritstone for HIV Vaccine

  • February 2, 2021
Eisai Signs a Research and Option Agreement with Numab to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer

Eisai Signs a Research and Option Agreement with Numab to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer

  • October 1, 2019
Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

  • January 18, 2019
Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies

Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies

  • December 19, 2018
Leidos Collaborates with GeoVax for the Development of Immunotherapies for Cancer

Leidos Collaborates with GeoVax for the Development of Immunotherapies for Cancer

  • November 20, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.